May 2017 - Page 2 of 3

MondayMay 15, 2017 9:49 am

ChineseInvestors.com, Inc. (CIIX) Projected To Reach Revenue of $14.8 Million by FY2020 in Consilium Global Research Report

ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research (http://nnw.fm/kKO7e). Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. The underlying market’s CAGR will expand at an 80% rate, the report said. Consilium sees CIIX as going through a huge transformation this year as it pursues a larger stake in the cannabis market. Headquartered in San Gabriel, California, CIIX offers a range of…

ThursdayMay 11, 2017 11:54 am

SinglePoint, Inc. (SING) Set to Capitalize on Payment Markets Opportunity in MMJ Industry after Congress Triggers Safe Harbor Protection

With the passage of the Rohrabacher-Farr amendment in the $1.1 trillion spending bill to fund the government until September 30, 2017, Congress continues its hands-off approach to the medical marijuana industry. Attached as a rider to the appropriations bill, Rohrabacher-Farr now allows marijuana dispensaries powerful ‘safe harbor’ protections. As a consequence, SinglePoint, Inc. (OTC: SING) is rebooting its initiatives, started two years ago, to be a ‘first mover’ in providing payment solutions to the cannabis vertical through its SingleSeed payments subsidiary. SinglePoint has been working with medical marijuana (MMJ) businesses for a long time, as GeekWire reported in August 2014…

WednesdayMay 10, 2017 9:00 am

Marijuana Stocks Drive Corporate Value by Delivering Automation, Technology and Diverse Application

CBDWire Editorial Coverage: The marijuana market is ripe with investment opportunities, and the leaders of the pack are those who demonstrate the vision and ability to increase corporate value. Be it through revolutionary technology, health applications, packaging and accessories, cultivation tools or other means, companies like SinglePoint, Inc. (SING) (SING Profile), Kush Bottles, Inc. (KSHB), Insys Therapeutics, Inc. (INSY), Solis Tek, Inc. (SLTK) and Medical Marijuana, Inc. (MJNA) are capturing their share of a burgeoning market and presenting investors with unique and exciting opportunities to climb aboard. In North America, the cannabis market was valued at approximately $7.2 billion in…

TuesdayMay 09, 2017 3:23 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by…

MondayMay 08, 2017 2:55 pm

ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing

Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange. Although the IPO was just launched on May 4 (http://nnw.fm/Lt5DO), its value took off, soaring over 26% on the first day and trading over 25% of the total volume on the exchange. ABcann is one of Canada’s major legal cannabis producers, and the public offers are set to provide even more investor benefits as the recreational marijuana market is now positioned for nationwide legalization. Raising capital was part of the company’s decision…

MondayMay 08, 2017 12:55 pm

India Globalization Capital, Inc. (NYSE: IGC) Positioned to Lead in Phytocannabinoid Pharmaceuticals

A study recently highlighted by the American Epilepsy Society (AES) at its 70th annual meeting focused on the potential of cannabidiol (CBD), a derivative of the cannabis plant, as a promising treatment for reducing both the frequency and severity of seizures in children with drug resistant epilepsies (http://nnw.fm/u3xAh). According to the study, patients who received CBD treatment exhibited over 45 percent mean reduction in seizures, and researchers were outspoken in support of further research. Cannabidiol is the most abundant non-psychoactive cannabinoid found in the cannabis plant. Both anecdotal evidence and pre-clinical research have suggested that CBD may have a broad…

FridayMay 05, 2017 2:37 pm

India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History

Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies. Cannabis’ history doesn’t begin in the 1960s. Scientists have dated burned cannabis seeds found in Siberia to 3,000 B.C., and mummified psychoactive marijuana has been found in tombs of individuals buried around 2,500 B.C. Fast forward a few thousand years and add laws, regulations, and cultural stigma, and behold one of the most disputed substances. In the 1850s, recreational cannabis was considered fashionable in the U.S., and it was…

ThursdayMay 04, 2017 12:27 pm

India Globalization Capital (NYSE: IGC) Strategically Staking Claims in the Medical Marijuana Markets

In a testament to its medical efficacy, 29 states and the District of Columbia have now legalized medical marijuana. This groundswell with state sanction and now widespread public acceptance has started a stampede of companies jockeying to profit from legalization. From the sale of oils and extracts to specialized cultivation, multiple companies are rushing into this new market hoping to cash in on surging demand. However, rushing in just might not be the right approach to making real money in this sector. There’s an old adage that says the way to create real wealth is to find out where everyone…

WednesdayMay 03, 2017 1:04 pm

ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO

All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities. Additional production facilities are planned to meet the expected supply short fall in the Canadian market when marijuana for recreational use is legalized next year. With its state-of-the-art cultivation facilities and established patient-client care systems, ABcann has the infrastructure in place to profit from that billion-dollar Canadian marijuana market. With adult use of marijuana set for legalization by July 1, 2018, the Canadian marijuana market is…

WednesdayMay 03, 2017 9:00 am

Paws Firmly Planted for Growth in Multibillion-Dollar Pet Health Market

CBDWire Editorial Coverage: Pets are the loyal, much-loved companions we humans can’t seem to live without, and when a beloved pet becomes ill, owners will generally do whatever it takes to restore these beloved companion animals to health. Various public companies are accomplishing the two-fold mission of improving the health of our four-footed friends while giving investors the opportunity to capitalize on a multibillion-dollar industry. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), VCA, Inc. (NASDAQ: WOOF), PetMed Express, Inc. (NASDAQ: PETS), Blue Buffalo Pet Products, Inc. (NASDAQ: BUFF) and IDEXX Laboratories, Inc. (NASDAQ: IDXX) are just some of the…

News and publishing service for CBD related companies

Contact us: 303.498.7722

Month: May 2017